Exclusive

Publication

Byline

Location

US Patent Issued to DAESANG on Sept. 8 for "Mutant of corynebacterium glutamicum with enhanced l-lysine productivity and method for preparing l-lysine using the same" (South Korean Inventors)

ALEXANDRIA, Va., Sept. 8 -- United States Patent no. 12,729,389, issued on Sept. 8, was assigned to DAESANG Corp. (Seoul, South Korea). "Mutant of corynebacterium glutamicum with enhanced l-lysine pr... Read More


US Patent Issued to XUCHANG UNIVERSITY on Sept. 8 for "Fermentation process for preparing postbiotic with by-product of wheat processing" (Chinese Inventors)

ALEXANDRIA, Va., Sept. 8 -- United States Patent no. 12,729,390, issued on Sept. 8, was assigned to XUCHANG UNIVERSITY (Xuchang, China). "Fermentation process for preparing postbiotic with by-product... Read More


US Patent Issued to BASF on Sept. 8 for "Bacillus cell with reduced lipase and/or esterase side activities" (German Inventors)

ALEXANDRIA, Va., Sept. 8 -- United States Patent no. 12,729,391, issued on Sept. 8, was assigned to BASF SE (Ludwigshafen am Rhein, Germany). "Bacillus cell with reduced lipase and/or esterase side a... Read More


US Patent Issued to KOREA INSTITUTE OF RADIOLOGICAL & MEDICAL SCIENCES on Sept. 8 for "Biomarker composition for predicting prognosis of brain disease caused by microplastic exposure and method for predicting prognosis using same" (South Korean Inventors)

ALEXANDRIA, Va., Sept. 8 -- United States Patent no. 12,729,392, issued on Sept. 8, was assigned to KOREA INSTITUTE OF RADIOLOGICAL & MEDICAL SCIENCES (Seoul, South Korea). "Biomarker composition for... Read More


US Patent Issued on Sept. 8 for "Agent interaction effects determination" (Swedish, Austrian Inventors)

ALEXANDRIA, Va., Sept. 8 -- United States Patent no. 12,729,393, issued on Sept. 8. "Agent interaction effects determination" was invented by Nikolaos Kavalopoulos (Uppsala, Sweden), Roderich Romhild... Read More


US Patent Issued to Deutsches Krebsforschungszentrum on Sept. 8 for "Immune enhancers" (German Inventors)

ALEXANDRIA, Va., Sept. 8 -- United States Patent no. 12,729,394, issued on Sept. 8, was assigned to Deutsches Krebsforschungszentrum (Heidelberg, Germany). "Immune enhancers" was invented by Nikolaus... Read More


US Patent Issued to CureVac Manufacturing on Sept. 8 for "Methods for RNA analysis" (German Inventor)

ALEXANDRIA, Va., Sept. 8 -- United States Patent no. 12,729,395, issued on Sept. 8, was assigned to CureVac Manufacturing GmbH (Tubingen, Germany). "Methods for RNA analysis" was invented by Aniela W... Read More


US Patent Issued to Thermo Finnigan on Sept. 8 for "Method for quantitative monitoring mRNA capping efficiency" (Massachusetts Inventors)

ALEXANDRIA, Va., Sept. 8 -- United States Patent no. 12,729,396, issued on Sept. 8, was assigned to Thermo Finnigan LLC (San Jose, Calif.). "Method for quantitative monitoring mRNA capping efficiency... Read More


US Patent Issued to Roche Sequencing Solutions on Sept. 8 for "Immune repertoire profiling by primer extension target enrichment" (California Inventors)

ALEXANDRIA, Va., Sept. 8 -- United States Patent no. 12,729,397, issued on Sept. 8, was assigned to Roche Sequencing Solutions Inc. (Pleasanton, Calif.). "Immune repertoire profiling by primer extens... Read More


US Patent Issued to ST. JOHN'S UNIVERSITY on Sept. 8 for "Circulating serum microRNA biomarkers and methods" (New York Inventors)

ALEXANDRIA, Va., Sept. 8 -- United States Patent no. 12,729,398, issued on Sept. 8, was assigned to ST. JOHN'S UNIVERSITY (Queens, N.Y.). "Circulating serum microRNA biomarkers and methods" was inven... Read More